Clinical trial

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of…

NCT00497601 · Banaras Hindu University, Other · Completed

Key facts

NCT number NCT00497601
Title A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Official title A Prospective, Single Center, Open-Label, Dose-Escalation Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Treatment Naïve Or Resistant Cases Of Visceral Leishmaniasis (Kala-Azar).
Lead sponsor Banaras Hindu University, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Visceral Leishmaniasis
Intervention type Drug
Interventions Amphotericin B fat emulsion in visceral leishmaniasis, Amphotericin B fat emulsion, Amphotericin B in fat emulsion
Enrollment 60
Start date Feb 1, 2007
Primary completion Jul 1, 2008
Completion Jul 1, 2008
First posted Jul 6, 2007
Last update posted Sep 12, 2008
Countries India

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies